The report opens with a distinction most readers would not think to make: not all telemedicine is the same kind of thing, and treating it as one category is, in the report’s own view, a policy mistake. Published in March 2014 by the EU eHealth Stakeholder Group under European Commission sponsorship, Widespread Deployment of Telemedicine Services in Europe separates the field into two types that it argues need entirely different legal and organizational treatment, and then spends the rest of its twenty-three pages building the case for eleven specific recommendations on the back of that distinction.
Two kinds of telemedicine, not one
The first category, which the report calls Medical Act type services, covers a registered doctor performing an already-existing medical act remotely, reading an X-ray from another building, examining a scan sent electronically. This kind of telemedicine was already widespread by 2014; the report treats its remaining problems as mostly cross-border legal and administrative issues, not fundamental design questions. The second category, Telemonitoring type services, is different in kind: multi-professional teams remotely tracking a patient’s physiological data over time. The report calls this “a disruptive innovation,” one that challenges how healthcare organizations are structured, how professional roles are divided, and how reimbursement rules are written, none of which were built with remote, continuous monitoring in mind.
Eleven recommendations
Out of that distinction comes the report’s core deliverable: eleven recommendations aimed at reaching what it calls “telemedicine for all by 2020.” They range from the practical to the structural: equal access regardless of location; digital literacy training specifically for health professionals, not just patients; transparency about which professional is actually treating a patient remotely; systematic monitoring of whether a given telemedicine service is adding real value rather than just novelty; data protection and informed consent handled explicitly rather than assumed; keeping a genuine human and professional touch in the process; user-driven design; integration with electronic health records; standardized document workflows built around the IHE Cross-Enterprise Document Workflow standard; extended professional liability insurance for cross-border cases; and standard contract templates to speed up adoption rather than reinventing legal terms for every new service.
Two of the eleven are worth pausing on, because they are less about telemedicine’s technology and more about the working relationships around it. The recommendation on professional-identity transparency exists because a remote consultation can obscure something an in-person visit never would: exactly which named professional, licensed where, is making a clinical judgment about a given patient. And the recommendation on cross-border liability insurance exists because a doctor licensed in one EU country reading a scan for a patient in another operates in a genuinely unsettled legal space, one the report treats as a barrier to adoption rather than a minor administrative detail.
What Scotland’s numbers show
The report’s most concrete evidence comes from national case studies in its annex, and Scotland’s stroke data is the starkest of them. At the time of writing, stroke was the third most common cause of death in Scotland and the leading cause of severe physical disability. An estimated thirty-five people had a stroke every day, 12,657 a year, and stroke accounted for seven percent of NHS beds and five percent of the NHS budget.
Against that backdrop, the report describes a specific operational change: routing stroke patients directly to the Scottish Ambulance Service, bypassing the usual GP consultation step. That single change cut the average time from symptom onset to CT scan from two and a half hours to one point seven five hours, a saving of nearly forty-five minutes inside the four-and-a-half-hour window during which thrombolysis, the clot-busting treatment for ischemic stroke, remains safe to administer. A national telestroke service was recommended to be fully operational by May 2012, and the report projects it could save one hundred forty patients per thousand strokes from death or physical dependency, twelve of those from death alone.
Catalonia’s network, by the numbers
A second national case study covers Catalonia’s Teleictus telestroke network, organized around ten health regions and eight hospitals. Each participating hospital had to be reachable within forty kilometers or one hour, and each had to perform at least ten thrombolysis treatments a year to stay in the network. As of the report, Teleictus served roughly one hundred stroke cases a year; a 2013 extension, adding GSM-reachable mobile neurologists, aimed to cover up to a thousand.
If you are reading this report today expecting current clinical protocol, it is worth being direct: this is a 2013-2014 policy snapshot, not a live medical standard. It should be read that way, and no figure here should substitute for current thrombolysis guidance. A separate distinction is worth naming so the two are not confused: Scotland’s teledermatology case study is a different clinical service from its stroke case study. Run by NHS Lothian over email, that dermatology service saved fifty percent of referrals to secondary care; in Switzerland, a comparable service found eighty percent of patient-submitted photos were good enough for a clinician to assess remotely. Neither figure has anything to do with the stroke numbers above, and the report keeps them in separate sections for that reason.
The European Commission has since gone further, commissioning a full market study on telemedicine published in October 2018, and the World Health Organization’s European Region has run its own broader telehealth surveys since, reporting in 2024 that telemedicine or remote monitoring was by then offered in seventy-seven percent of responding countries. The 2014 report described here is the origin point of that trajectory, not its current state.